Cite

    D Choquette et al.. “FRI0230 Retention rates of tnf inhibitors and abatacept used as a first biologic dmard in the treatment of rheumatoid arthritis: 8 years of experience from the rhumadata® registry.” Annals of the rheumatic diseases, vol. 76, n.d., pp. 571–572. http://access.bl.uk/ark:/81055/vdc_100135163782.0x000060